Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea

Combination therapy with interferon alpha (IFN-α) and ribavirin for 24 or 48 weeks according to HCV genotype has improved the overall sustained virological response (SVR) rates to approximately 40%. The aim of this study was to investigate the long-term efficacy of combination therapy with IFN-α and...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kim, Jie-Hyun, Han, Kwang-Hyub, Lee, Kwan Sik, Park, Young Nyun, Ahn, Sang Hoon, Chon, Chae Yoon, Moon, Young Myoung
Médium: Artigo
Jazyk:Inglês
Vydáno: Yonsei University College of Medicine 2006
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687818/
https://ncbi.nlm.nih.gov/pubmed/17191307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2006.47.6.793
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky